Parexel, a leading global clinical development partner has announced the launch of the Parexel Biotech Incubator, a new initiative anchored at the company's North Hills Innovation District global headquarters in Raleigh.

The initiative connects early-stage therapeutics companies with the clinical and regulatory expertise they need to advance their programs. 

The incubator launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm, and builds on Parexel's growing commitment to supporting early-stage innovation in collaboration with the venture community.

The Parexel Biotech Incubator is designed to support emerging therapeutics companies at a stage when development strategy is still taking shape. 

Participating companies will have access to Parexel's clinical and regulatory expertise - including guidance on development planning, regulatory strategy and clinical trial design - alongside shared physical space that puts them in direct proximity to Parexel's Raleigh-based team and provides a collaborative home rather than resources and investment alone.

"Reaching innovators at the earliest stages of their development journey, before clinical programs are formally structured, is where we can have the greatest impact. That is exactly what this initiative is designed to do," said Peyton Howell, Chief Executive Officer of Parexel. 

"The incubator builds on our broader commitment to investing in early-stage innovation alongside leading venture firms, and our inaugural partnership with Cape Fear BioCapital deepens our roots in one of the most dynamic life sciences ecosystems in the country,” added Howell.

'The Parexel Biotech Incubator represents the next stage in Parexel Biotech's evolution and extends our long-standing commitment to the biotech community," said Jim Anthony, Chief Commercial Officer and President, Parexel Biotech. 

"By bringing our clinical and regulatory expertise to emerging innovators earlier in their development journeys, we can help companies make smarter development decisions, build stronger plans and position promising programs for lasting progress,” added Anthony.

"Working together with Parexel, we are dedicated to supporting emerging companies and connecting them with development expertise at a stage when strategic guidance can make a meaningful difference. Our partnership reflects a shared commitment to strengthening the support and capital available to innovators across the state,” said Dave Ousterout, General Partner at Cape Fear BioCapital.